Women have exclusively borne the side effects of hormonal contraceptives since their invention. Is it time for men?
Editor

Medicine has been searching for a hormonal contraceptive for men for some time.  Recent news trumpeted the withdrawal of a number of men from clinical trials of male hormonal contraceptive injections due to the side effects.  While this editor recently … Continue reading

Share Button

Dwarfism, Chemical Limb Lengthening, and Informed Consent
avatar

According to a recent article in the popular press, a California based biotech firm, BioMarin Pharmaceuticals, has completed Phase 2 of a clinical trial for a drug that would partially suppress the expression of the Achondroplasia gene in a child’s … Continue reading

Share Button

Restoring Study 329

Today the BMJ published a re-analysis of the data in Study 329. The results of this study, funded by GlaxoSmithKline were first published in 2001 in the prestigious Journal of the American Academy of Child and Adolescent Psychiatry. That article … Continue reading

Share Button

Misdirected Anger at Planned Parenthood Video:
Don’t Stigmatize Women Who Donate Fetal Tissue

Guest post by Elizabeth Yuko (Fordham University) Yesterday, a group that calls itself the “Center for Medical Progress” released a video which shows a Planned Parenthood doctor discussing various aspects of the fetal tissue donation process. Filmed undercover and heavily edited, … Continue reading

Share Button

“The Drug that Cried ‘Feminism'”

Branded as “The Little Pink Pill” and “Female Viagra,” flibanserin, Sprout Pharmaceuticals’ only drug, was recently resubmitted to the Food and Drug Administration for approval for hypoactive sexual desire disorder (HSDD), a questionable condition promoted by pharmaceutical companies to sell … Continue reading

Share Button

Twenty Years of Bioethics at UNESCO

In celebration of the 20th year of its Bioethics Programme, UNESCO has published an edited anthology, Global Bioethics: What For? It is freely available in its entirely online and features short essays by IJFAB advisory board member and one-time guest-contributor Daniel Callahan as … Continue reading

Share Button

Last Week Tonight with John Oliver: “Marketing to Doctors”

One analysis claimed that in 2013 nine out of the top ten drug makers spent more on marketing than they did on research. Drug companies are a bit like high-school boyfriends: they’re much more concerned with getting inside you than being effective … Continue reading

Share Button

Biotech Drugs In Colombia: Are Colombian Bodies Really That Different?

As a feminist working on bioethics, I often turn to the reality of material singularity as a way to argue for more specificity in our dealings with the matter of living bodies. What do I mean by “material singularity?” This … Continue reading

Share Button

Biotech Drugs In Colombia:
Are Colombian Bodies Really That Different?

As a feminist working on bioethics, I often turn to the reality of material singularity as a way to argue for more specificity in our dealings with the matter of living bodies. What do I mean by “material singularity?” This … Continue reading

Share Button

“Health Researchers Will Get $10.1 Million to Counter Gender Bias in Studies”

The NIH has launched a program to counter gender bias in medical research. Fortunately policy makers seem to be listening to feminist bioethicists — rather than Fields and his ilk — in at least this instance! Find the story at … Continue reading

Share Button

Research into Sex Differences – Carrots and Sticks

In this piece from Scientific American, R. Douglas Fields argues that the new US National Institutes of Health policy, which is intended to drive research in sex differences, is a major step in the wrong direction. The new policy requires … Continue reading

Share Button

Ebola, and the ethics of research in pandemics and other disasters

The current outbreak of Ebola in west Africa has prompted a fair amount of debate around the ethics of epidemic control, containment, and intervention. Some of this discussion looks at what kind of intervention (use of experimental treatment? compassionate use? … Continue reading

Share Button